» Articles » PMID: 17179366

Cerebral Blood Volume Measurements and Proton MR Spectroscopy in Grading of Oligodendroglial Tumors

Overview
Specialties Oncology
Radiology
Date 2006 Dec 21
PMID 17179366
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The purpose of this study was to determine whether perfusion-weighted imaging (PWI) and proton MR spectroscopy (MRS) are useful in differentiating high- and low-grade oligodendroglial tumors.

Materials And Methods: PWI and MRS studies of 22 patients with histologically proven oligodendroglioma or oligoastrocytoma (13 low-grade and nine anaplastic tumors) were retrospectively reviewed. PWI of 14 subjects was performed with a dynamic contrast-enhanced susceptibility-weighted echo-planar technique. Intratumoral relative cerebral blood volume ratio was calculated and normalized to the same value in contralateral normal-appearing white matter. Multivoxel MRS was performed with a point-resolved spectroscopy sequence at a TE of 135 milliseconds in 20 patients and with the addition of a TE of 30 seconds in 17 patients. MRS data were expressed as intratumoral metabolite ratios (choline to creatine [Cho/Cr], choline to N-acetyl aspartate, N-acetyl aspartate to creatine, and myoinositol to creatine).

Results: Relative cerebral blood volume ratios were significantly different (p = 0.004) between low-grade (1.61 +/- 1.20) and high-grade tumors (5.45 +/- 1.96). The optimal relative cerebral blood volume ratio cutoff value in identification of anaplastic oligodendroglial tumors was 2.14. Analysis of MRS data showed significantly higher Cho/Cr ratios (p = 0.002) in high-grade than in low-grade tumors. A Cho/Cr ratio cutoff value of 2.33 had the highest accuracy in identification of high-grade tumors.

Conclusion: Relative cerebral blood volume measurement and MRS are helpful in differentiating low-grade from anaplastic oligodendroglial tumors.

Citing Articles

Revisiting oligodendroglioma grading in the 2021 WHO classification: calcification and larger contrast-enhancing tumor volume may predict higher oligodendroglioma grade.

Lee D, Choi K, Han K, Choi S, Lee N, Ahn S Neuroradiology. 2024; 66(9):1527-1535.

PMID: 39014271 DOI: 10.1007/s00234-024-03430-y.


Diagnostic Utility of Integration of Dynamic Contrast-Enhanced and Dynamic Susceptibility Contrast MR Perfusion Employing Split Bolus Technique in Differentiating High-Grade Glioma.

Malik V, Kesavadas C, Thomas B, N D, K K Indian J Radiol Imaging. 2024; 34(3):382-389.

PMID: 38912247 PMC: 11188723. DOI: 10.1055/s-0043-1777742.


Comparative study between dynamic susceptibility contrast magnetic resonance imaging and arterial spin labelling perfusion in differentiating low-grade from high-grade brain tumours.

Patil V, Malik R, Sarawagi R Pol J Radiol. 2023; 88:e521-e528.

PMID: 38125817 PMC: 10731442. DOI: 10.5114/pjr.2023.132889.


Hemodynamic Imaging in Cerebral Diffuse Glioma-Part A: Concept, Differential Diagnosis and Tumor Grading.

Guida L, Stumpo V, Bellomo J, van Niftrik C, Sebok M, Berhouma M Cancers (Basel). 2022; 14(6).

PMID: 35326580 PMC: 8946242. DOI: 10.3390/cancers14061432.


Comparative evaluation of intracranial oligodendroglioma and astrocytoma of similar grades using conventional and T1-weighted DCE-MRI.

Gupta M, Gupta A, Yadav V, Parvaze S, Singh A, Saini J Neuroradiology. 2021; 63(8):1227-1239.

PMID: 33469693 DOI: 10.1007/s00234-021-02636-8.